Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice

Gloria H. Y. Lin, Yuanqing Liu, Thanuja Ambagala et al. · 2010

Read Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice by Gloria H. Y. Lin, Yuanqing Liu, Thanuja Ambagala et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011003.txt.

Description

Gloria Lin, Yuanqing Liu, Thanuja Ambagala and co-authors published this cancer immunotherapy study in PLOS ONE in 2010. Antibodies that stimulate the immune receptor 4-1BB can shrink tumors in mice, expanding both T cells and innate immune cells. Depletion experiments could not say which cells must receive the signal directly, so the authors designed a study around memory T cells.

They found that memory T cells re-activated outside the body controlled an established tumor better than resting memory cells. The activated cells kept dividing and entered the tumor, and testing which cells truly need the 4-1BB signal refines how the therapy works. Lin and colleagues narrow the list of essential cellular targets. Precise targets mean future agonist drugs can be tuned to the cells that actually deliver the cure.

Catalog record

CREATORGloria H. Y. Lin, Yuanqing Liu, Thanuja Ambagala et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011003

Browse the full library · About the Tower of Babel